Marrone Bio Innovations’ Marrone Michigan Manufacturing Facility Recognized by the Michigan Agri-Business Association for Contributions to Sustainable Agriculture

November 13, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, is pleased to announce that its Marrone Michigan Manufacturing (M3) facility in Bangor, Michigan has received a 2014 “Green Agribusiness Award” from the Michigan Agri-Business Association (MABA).

The awards recognize companies for pursuing sustainability requirements across the scope of agricultural production that help agriculture further protect water quality and the Great Lakes, and achieve the greatest possible yields while protecting the environment.

“Every day, consumers are more connected to our food system and they want to know that Michigan agriculture is producing food in a sustainable way,” said Jim Byrum, President of MABA.  “In addition, our industry knows the value of protecting our air, water and Great Lakes for coming generations. By pursuing a wide range of sustainability criteria under the Green Agribusiness Designation Program, companies across the state, such as Marrone Bio Innovations, are leading the way on this important issue.”

The M3 facility, which held its Grand Opening on July 1, 2014, is a wholly-owned subsidiary of MBI. Currently three MBI product lines are being produced at the M3 facility: REGALIA® and REGALIA Rx®, which are biofungicides, GRANDEVO®, which is a bioinsecticide and ZEQUANOX®, which is a biomolluscicide to control invasive zebra and quagga mussels.

“On behalf of the entire MBI team, I would like to thank the Michigan Agri-Business Association for recognizing our contributions to sustainable agriculture,” said Gordon Grove, MBI’s M3 Plant Manager.  “Southwest Michigan is positioned at the forefront of a growing global movement to firmly establish biologically based technologies as the foundation in agriculture, turf, ornamental and water treatment markets. As the world looks for answers to sustainably feed 9 billion people, M3 and Southwest Michigan will be providing safe, smart and effective solutions to big challenges confronting humanity and the environment.”

*******

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

As previously disclosed in the Company’s Form 8-K dated September 3, 2014, the Company’s Audit Committee has commenced an internal investigation. The Audit Committee has not yet concluded its investigation and the Company does not expect it will be in a position to discuss financial results until after the investigation is completed.

The uncertainty surrounding the timing and results of the Audit Committee investigation could impact the timing of Company’s discussion of its financial results. Additional relevant information concerning developments in the Audit Committee investigation may be found in the Company’s filings with the Securities and Exchange Commission from time to time.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

Marrone Bio Innovations CEO Pam Marrone Receives Agrow Award for Best Manager With a Strategic Vision

DAVIS, Calif., Oct. 30, 2014 — Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products, announced today that its Founder and Chief Executive Officer Pam Marrone has received a 2014 Agrow Award for “Best Manager with Strategic Vision.” Marrone was honored at the Agrow Awards’ 2014 ceremony and dinner last night in Amsterdam.

The inaugural “Best Manager with Strategic Vision” award recognizes a manager who through a strategic initiative was able to achieve clearly identifiable targets in areas such as new product launches, new market penetration and company performance.

“I am extremely honored to have received this prestigious award,” said Pam Marrone, CEO of MBI. “Our strategic vision is focused on discovering and developing effective and environmentally responsible bio-based products that promote plant health and control unwanted pests in agriculture. We look forward to continuing to execute on this vision and bringing new agricultural innovations to market through Integrated Pest Management. On behalf of my colleagues at MBI who are critical to making our vision a reality, I would like to thank the Agrow Awards for honoring our company with this award.”

MBI was also a 2014 Agrow Award finalist for “Best Industry Collaboration” for its partnership with DSM Food Specialties B.V. (DSM), a Netherlands-based manufacturer of specialty ingredients for international food and beverage industries. MBI’s strategic partnership with DSM is focused on maximizing the potential power, reach and value of novel active ingredients for bio-based products that promote plant health and control unwanted pests in agriculture. Through this collaboration, both companies and their respective industries at either end of the food supply chain stand to benefit from the identification of new bio-based solutions for improved crop production and food safety.

The prestigious Agrow Awards, presented by Agrow, a leading information provider for the global crop protection industry, features 13 categories in areas such as R&D, formulation, innovation, collaboration, marketing, business strategy and corporate responsibility. Candidates were judged by an independent panel of industry experts, before announcing the winners on October 29th.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Brian Ahrens Joins Marrone Bio Innovations as Vice President of Sales

October 27, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the Brian Ahrens smallagriculture, turf and ornamental and water treatment markets, today announced that Brian Ahrens has joined the company as its Vice President of Sales.   In this role, Ahrens will be responsible for driving U.S. and international sales of MBI’s portfolio of products to growers through distributors and retailers of agriculture products.

Pam Marrone, Chief Executive Officer of Marrone Bio Innovations, said, “There are significant domestic and international growth opportunities for our bio-based agricultural solutions as more growers and companies put an emphasis on environmental sustainability and improved agricultural productivity.  Brian strengthens our management team and sales organization as we add depth and build out our sales team in order to capitalize on these opportunities.  Brian will play a critical role in driving sales and expanding our market reach for our bio-based products, which promote plant health and control unwanted pests in agriculture and water.”

A veteran of the agriculture industry with 20 years of business and industry experience, Ahrens joins MBI from ADAMA Agriculture Solutions (formerly Mahkteshium Agan – MANA) where he served as Strategic Business Leader, Innovation Leader, Northern Regional Business Manager and Senior Product Manager. Prior to his time at ADAMA, Ahrens held multiple positions with BASF Corporation, Bayer CropScience, Aventis CropScience and Rhône-Poulenc Ag Company.  Ahrens has a B.S. in Agricultural Business from Iowa State University, with a concentration in marketing and sales.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

As previously disclosed in the Company’s Form 8-K dated September 3, 2014, the Company’s Audit Committee has commenced an internal investigation. The Audit Committee has not yet concluded its investigation and the Company does not expect it will be in a position to discuss financial results until after the investigation is completed.

The uncertainty surrounding the timing and results of the Audit Committee investigation could impact the timing of Company’s discussion of its financial results. Additional relevant information concerning developments in the Audit Committee investigation may be found in the Company’s filings with the Securities and Exchange Commission from time to time.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

Zequanox® Achieves 100% Mortality for Invasive Mussels in Minnesota Lake

Biological product used at Christmas Lake near Minneapolis kills zebra mussels

Treatment Area - 11 DAT (800x600)

Christmas Lake treatment area in Shoreview, Minnesota, 11 days following Zequanox treatment, which resulted in 100 percent mortality of the invasive mussels.

DAVIS, Calif., September 30, 2014 – Marrone Bio Innovations, Inc. (MBI) [Nasdaq: MBII], a leading global provider of bio-based pest management and plant health products announced today the successful results of a Zequanox treatment conducted at Christmas Lake in Shorewood, Minn.

Minnesota Department of Natural Resources and the Minnehaha Creek Watershed District’s (MCWD) Aquatic Invasive Species (AIS) Program requested Zequanox treatment from MBI after discovering zebra mussels near the public boat launch. The non-chemical product approved for use in open water was applied to a 50 by 60 foot containment area with an average depth of 2.5 feet. Before treating, there were approximately 5,000 live mussels in the enclosure.  The treatment began on September 8 and eleven days later results showed 100 percent mortality of the zebra mussels in the treatment area.

“We are extremely pleased that Zequanox was so effective in the Christmas Lake treatment,” said Keith Pitts, Vice President of Regulatory Affairs for MBI. “The watershed district and the Minnesota DNR have been great partners, and we’re happy to continue to see proven results for invasive mussel control. It’s a comforting outcome for the public as well, because this solution is more environmentally friendly than other mussel control products and can be administered without harming people, pets or the environment.”

MCWD staff monitored the effectiveness of Zequanox by counting dead mussels over time in the treatment area using collected mussels placed in cages and by searching the area for mussels attached to rocks.  Also, they monitored aquariums in a laboratory that held treated water and mussels from Christmas Lake.

“Marrone Bio Innovations has been a key partner in the first phase of our response,” said Craig Dawson, director of MCWD’s AIS Program. “What we’ve learned from the treatment bodes well for future efforts to contain zebra mussel infestations, especially when they’re caught early like the Christmas Lake case.”

Invasive mussel populations are now prevalent in major waterways throughout the country, including the Great Lakes Region as well as the Mississippi, Arkansas, Tennessee and Colorado rivers. The mussels have a significant economic and environmental impact on recreational water use. Colonies of invasive zebra and quagga mussels negatively impact native mussel populations, disrupt the natural ecosystem and cause proliferation of toxic blue-green algae. They decrease game fish populations, which can have a serious effect on the economic health of the fishing industry. Swimmers run the risk of injury from the invasive mussels’ sharp shells, and water intakes from infested lakes and rivers used for irrigation, fire suppression and drinking water can suffer impeded or blocked flow and damage to infrastructure and equipment.

Zequanox is the industry’s only selective and environmentally compatible molluscicide, which was first approved by the EPA in 2012 for mussel control in enclosed systems and infrastructures for energy producers, manufacturing companies and golf courses. The EPA approved Zequanox in July for open water use and as a result, the product is now available to private waterfront owners and natural resource managers as an effective solution to control existing populations of invasive mussels or knock back new infestations without the use of environmentally harmful treatments, such as potash and copper-based products.

Composed of dead cells derived from a naturally occurring soil microbe, Zequanox controls mussels in all life stages. Unlike toxic treatments, such as potash and copper-based solutions, Zequanox is biodegradable and noncorrosive. In addition, Zequanox is highly selective to control only the invasive zebra and quagga mussels, is effective in a broad range of water conditions and according to the EPA, its active ingredient has “low toxicity and presents little risk to non-target organisms.”

Zequanox is applied directly into an open body of water, such as a lake or river, using standard injection equipment. Treatments can occur during any time of the day while people and pets are present, and can be completed within hours. The product offers additional flexibility because it is proven to be effective in a broader range of water conditions.

The product offers a zero hour re-entry interval, so there is no waiting period after treatment that might interfere with commercial or recreational use of a waterway, such as fishing, swimming or boating. The U.S. EPA determined Zequanox was exempt from the requirement of a food tolerance, which indicates that there is no concern with using treated water to irrigate crops or that eating fish caught in waters treated by Zequanox poses any risk to consumers.

Traditional chemical products do exist to effectively treat invasive mussel populations, however they can leave damaging environmental impacts. Solutions containing potash (potassium chloride, KCI) and copper based products can kill endangered and threatened native mussel species.  Also, use of potash- and copper-based products lead to public heath concerns resulting in restricted drinking water use from reservoirs and prohibitions on recreational use for extended periods. Both chemicals are toxic to non-targeted organisms and persist in the environment, causing prolonged ecosystem exposure.

###

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs,  hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-Q that the Company filed with the Securities and Exchange Commission on May 15, 2014.

Marrone Bio Innovations Receives Patent for Use of Chromobacterium to Control Corn Rootworm Larvae Infestation

September 11, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that it has received a patent for the use of Chromobacterium, a naturally occurring bacterium with demonstrated insecticidal and miticidal capabilities. The patent protects the uses of Chromobacterium formulations, compositions and compounds to control corn rootworm larvae infestation. more »

Scott Peoples Joins Marrone Bio Innovations as Vice President of Marketing

Peoples to drive demand creation of MBI’s suite of bio-based pest management and plant health products

MBI_Peoples_Scott_9470_R_W small (1)

September 09, 2014, DAVIS, CA — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that Scott Peoples has joined the company as its Vice President of Marketing.  In this role, Peoples will be responsible for driving demand creation of MBI’s suite of products to farmers and growers across the agriculture industry. He will also provide leadership in product management and business development activities.

“We are pleased to welcome Scott to MBI’s senior management as he will play a critical role in driving demand and penetration of our bio-based products, that promote plant health and control unwanted pests in agriculture and water,” said Pam Marrone, Chief Executive Officer of Marrone Bio Innovations.  “The global market for bio-based agricultural solutions remains early in its growth curve and MBI is well-positioned to capitalize on this growth with our strengthened management team, our growing suite of effective and environmentally responsible products, new collaborations and partnerships, and our growing pipeline of new business opportunities.”

A 19 year veteran of the agriculture industry with 29 years of business experience, Peoples joins MBI from BASF where he served in several roles, including marketing manager, business development manager, global strategic marketing manager and most recently, Senior Global Business Manager for Herbicide Tolerance.  Prior to BASF, Peoples held several positions at Monsanto, including field representative, and marketing and business manager of a Monsanto subsidiary focused on application equipment.  Prior to his time in the agriculture industry, he spent nearly 10 years in the laboratory robotics industry with DuPont, Tecan, and as a founder of Leap Technologies.  Peoples has a chemistry degree with a minor in biology from the University of Delaware, and an MBA from the University of North Carolina, Chapel Hill Executive program.

 ****

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials.  Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

Marrone Bio Innovations Announces Registration of Bioinsecticide VENERATETM In California

Multiple modes of action, MRL tolerance exemption, and favorable environmental profile combine to deliver a powerful new tool for fruit, nut, vine and vegetable growers

Logo_Venerate_280DAVIS, Calif., August 27, 2014 — Marrone Bio Innovations, Inc. (MBI), (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that its VENERATETM Bioinsecticide is now registered in California.  VENERATE is a new tool to help California growers control crop-damaging insect pests, fight the development of insect resistance and reduce pesticide residues on fruits and vegetables. more »

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. ...
  10. 23